As part of that, the goal of this new collaboration with Qualcomm Life is to help improve adherence to daily medicines that treat symptoms of COPD. Qualcomm Life and Boehringer Ingelheim will collaborate to develop the next version of Boehringer ’s blockbuster drug, which is expected to be approved by regulators in Europe this year. According to a statement from both companies, the partnership will develop the prototype for a small, wireless, disposable sensor module running on low power that will automatically send data both to its user and their healthcare provider via Qualcomm Life’s 2net Platform.
Qualcomm Life and Boehringer Ingelheim will collaborate to develop the next version of Boehringer ’s blockbuster drug, which is expected to be approved by regulators in Europe this year. According to a statement from both companies, the partnership will develop the prototype for a small, wireless, disposable sensor module running on low power that will automatically send data both to its user and their healthcare provider via Qualcomm Life’s 2net Platform.